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WHAT THIS PAPER ADDS
 The main ﬁnding of this study is that pEVR was associated with a reduced operation time and length of stay in non-selected
patients. The primary beneﬁt of pEVR is reduction in postoperative complications, although pEVR is associated with an
increased number of intraoperative reinterventions to the access site. Operator experience was the only predictor of technical
success of pEVR.a r t i c l e i n f o
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Introduction: The effectiveness of percutaneous access with large vessel closure (pEVR) in non-selective
groups of patients undergoing endovascular aneurysm repair (EVR) remains unclear. This study aims to
identify factors that predict success in pEVR, performed using percutaneous access and the Prostar XL
(Abbott Vascular, Redwood City, Calif) closure device.
Method: Consecutive patients who underwent pEVR between April 2010 and March 2011 were identiﬁed
from a prospectively maintained database. Procedural and postoperative outcomes were compared with
consecutive patients who underwent endovascular aneurysm repair using standard open femoral access
between April 2008 and March 2009. To determine the predictors of technical success of pEVR, the
association between clinical, anatomical and procedural variables with technical success, were examined
in a multiple logistic regression model.
Results: pEVR was attempted in 186 common femoral arteries (CFAs) with a technical success rate of
95.2% (177/186). Conventional open femoral access in the historic control group was performed in 208
CFAs. pEVR was associated with a reduced operation length (131 min [105e152] versus 150 min [124
e195], p0.001) and length of stay (2 days [2e5] versus 4 days [2e7], p ¼ 0.01) in patients under-
going infrarenal EVR.
In secondary analysis of outcomes following percutaneous access in 91 CFAs, pre-operative renal failure,
CFA depth (min and max), CFA diameter (min and max) and operator experience predicted success of
percutaneous access in univariate analysis. Operator experience was the only independent predictor of
technical success (p ¼ 0.05) after adjustment for all confounding variables.
Conclusion: pEVR using the Prostar XL device is effective in the majority of patients. In this study there
were beneﬁts in terms of reduced postoperative complications, shorter procedures and decreased
lengths of stay. Operator experience is a predictor of technical success for pEVR, irrespective of clinical
and morphological characteristics at baseline.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.etcalfe).
ciety for Vascular Surgery. PublishIntroduction
Percutaneous access for endovascular aneurysm repair coupled
with a percutaneous large vessel closure (pEVR) has demonstrated
safety and feasibility in several prospective studies.1e3 This tech-
nique offers an attractive alternative to conventional femoral arteryed by Elsevier Ltd. All rights reserved.
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postoperative morbidity, improve pushability of large devices,
reduce the duration of surgery and enhance surgical recovery. A
signiﬁcant proportion of contemporary patients undergoing EVR
are at risk of local access complications by virtue of diabetes,
obesity and groin scarring.
Despite exclusion of these high risk patients from several series
evaluating the role of percutaneous access in EVR,4,5 recent data
suggest this group of patients can be treated percutaneously with
fewer local access-related complications.6 The effectiveness of
percutaneous techniques in non-selective groups of patients
undergoing EVR remains unclear. The present study compared
procedural and postoperative outcomes in patients undergoing
EVRwith conventional open femoral and percutaneous access, with
large vessel closure. In addition the inﬂuence of clinical, morpho-
logical and procedural variables on the technical success of pEVR,
was investigated using regression analysis.
Methods
Patients
Consecutive patients who underwent elective infrarenal
abdominal EVR, fenestrated (FEVR) and thoracic endovascular
aortic repairs (TEVR) using percutaneous access between April
2010 and March 2011 were identiﬁed from a prospectively main-
tained database. This cohort of patients treated with percutaneous
access and large vessel closure using the Prostar XL device (Abbott
Vascular, Redwood City, Calif), was compared with a group of
consecutive patients who underwent EVR and TEVR using standard
open femoral access between April 2008 and March 2009, (before
the introduction of pEVR at our institution). One of the four
surgeons who contributed to this series preferentially used
conventional CFA cutdown. Cases performed by this surgeon were
therefore excluded from our analysis in both the percutaneous
access and the historical control group. Data regarding the duration
of operation, length of stay and rate of technical success, reinter-
ventions and complications were obtained from a clinical database.
Technical success was deﬁned as freedom from additional inter-
ventions to the access site, either intraoperatively or within 30 days
post-operatively.
To determine the predictors of technical success of pEVR, we
prospectively obtained baseline clinical, anatomical and procedural
variables for a cohort of 57 consecutive patients undergoing elec-
tive EVR and TEVR between November 2010 and March 2011.
Three-dimensional volume-rendered reconstructions of computed
tomographic angiography (CTA) scans were used to deﬁne the
following common femoral artery (CFA) parameters; length (from
inguinal ligament to bifurcation), minimum (MIN) and maximum
(MAx) depth (as measured on axial sections from the nearest skin
surface), min and max outer wall diameter, and anterior and
posterior wall calciﬁcation. Calciﬁcation was measured as the
combined circumferential length of calcium plaques divided by half
the vessel circumference for both the anterior and posterior wall,
with measurements taken on axial images every 1 cm from the
inguinal ligament to the CFA bifurcation. Averages were calculated
for both the anterior and posterior walls. Operator experience was
deﬁned as >20 percutaneous access procedures performed as
primary operator, a cut-off based on requirements of the device
company for independent use.
Absolute contraindications to percutaneous access included
patients with connective tissue disorders (Marfans and Ehlers-
Danlos) and the use of a sheath 24 French. Relative contraindi-
cations consisted of groin scarring (previous open femoral artery
exposure), severe CFA calciﬁcation and a minimum CFA depth ofgreater than 55 mm on CT imaging. Previous transfemoral angi-
ography, inguinal and femoral hernia repair were not considered
relative contraindications. Where relative contraindications were
present, the decision regarding which method of CFA access to use
was made on a case-by-case basis.
Technical details
Percutaneous access was achieved using the “preclose” tech-
nique (Prostar XL device, Abbott Vascular, Redwood City, Calif),
which has been described in detail elsewhere.7 In brief; the CFAwas
accessed using a 16G needle under ultrasound guidance and
a standard wire inserted. A small longitudinal skin incision was
made and a 5-F sheath advanced over the wire. Under ultrasound
guidance, blunt dissection of a tract along the path of the sheath
was performed to facilitate entry of the introducer sheath through
the deep fascia. The standard wire was replaced with an Amplatz
wire, over which the Prostar XL device was inserted at an angle of
45. The device was then deployed according to the manufacturer’s
guidelines and replaced, over the Amplatz wire, with a sheath one
calibre smaller than the stent sheath size to be inserted in that side.
Following deployment of the stent graft and reinsertion of the
sheath with the introducer, the sutures were cleaned with hepa-
rinized saline solution and the pre-formed knot was slid down,
whilst the sheath with its introducer in situ were removed. The
Amplatz wire was removed when haemostasis was achieved, the
knots tightened and locked. Where a small bleed continued,
external pressure was applied over the puncture site for 10 min to
ensure haemostasis.
Where bleeding continued following sheath removal andaperiod
of manual compression, a size 6 Fogarty catheter was advanced over
the Amplatz wire into the lumen, inﬂated and pulled back until
bleeding was controlled. A longitudinal open cutdown directly on to
the CFA along the line of the Fogarty catheter was then performed.
The arteriotomy was then closed with 500 prolene sutures.
Aortic stent grafts used included Zenith (Cook, Bloomington,
Ind), Endurant (Medtronic, Santa Rosa, Calif), and Valiant (Med-
tronic) devices. During in-hospital follow-up, puncture sites and
groin incisions were examined and duplex ultrasonography (DUS)
was obtained to assess for the presence of false aneurysms.
Statistical analysis
All analyses were performed on a per-groin basis. Continuous
variables are expressed as mean  standard deviation or as median
and interquartile range where appropriate. Categorical variables
are presented as percentages. Differences between treatment
groups were assessed using a combination of Chi-square test and
unpaired t-tests, for categorical and continuous data respectively.
Where cross tabulation frequencies were less than 5, the Fisher
exact test was used. In a secondary analysis, logistic regression
models were constructed to assess the impact of various baseline
variables on the technical success of percutaneous access. Variables
demonstrating an association with success of percutaneous access
(P0.10) were considered in a multiple logistic regression model
where a p value of 0.05 indicated statistical signiﬁcance. All
statistical analyses were performed with the use of SPSS version
16.0 (SPSS Inc., Chicago, Illinois).
Results
Between April 2010 and March 2011, percutaneous access for
elective EVR, FEVR or TEVR was attempted in 186 CFAs (Table 1). In
the historic control group, treated with conventional open access
between April 2008 and March 2009, 208 CFAs were accessed for
Table 2
Uni and multifactorial analysis for successful percutaneous access.a
Variables Success
(n ¼ 81)
Failure
(n ¼ 9)
P value
(Univariate
analysis)c
P value
(Multivariate
analysis)d
Age 74.0  7.7 77.1  9.4 0.26 n/ab
Female (%) 11 0 n/ab
BMI 27.1  3.6 28.7  5.5 0.31 n/ab
DM (%) 8.6 33.3 0.21 n/ab
Cr >120 (%) 23.5 33.3 0.08 0.38
Groin scarring (%) 13.6 11.1 0.40 n/ab
CFA depth
Max 41.3  15.3 53.7  23.0 0.03 0.33
Min 29.4  9.5 35.8  12.7 0.07 0.85
CFA diameter
Max 12.7  2.0 14.0  2.6 0.07 0.32
Min 9.6  1.6 10.8  1.1 0.04 0.34
CFA length 47.2  11.4 47.4  10.1 0.94 n/ab
Anterior calciﬁcation 2.9  4.0 1.4  1.7 0.29 n/ab
Post calciﬁcation 8.3  9.0 4.6  5.2 0.26 n/ab
Experienced surgeon (%) 66.7 44.4 0.00 0.05
a Plus-minus values are means  SD. DM denotes diabetes mellitus, Cr creatinine,
CFA common femoral artery.
b na ¼ not applicable (variable was not included in the multifactorial model).
c Fishers exact test compared categorical variables. Continuous variables were
compared using Independent t tests.
d Multiple logistic regression analysis using variables that demonstrated an
interaction with level of signiﬁcance p < 0.10.
Figure 1. Technical success by sheath size.
Table 1
Comparison between O-EVR and P-EVR cohorts.a
Characteristic Open approach Percutaneous approach P valueb
Patients 111 103 e
Femoral arteries 208 186 e
Age 74.3  8.0 73.9  9.0 0.74
Female, % 12.6 19.2 0.18
DM, % 12.5 14.4 0.51
Cr >120, % 19.2 16.7 0.65
Dialysis, % 2.0 1.1 0.60
HD, % 46.1 42.4 0.61
Procedure
TEVR 13 16 e
Fen 10 16 e
EVR 88 71 e
Op length
TEVR 158 (150e378) 120 (105e120) 0.27
Fen 210 (128e228) 180 (139e213) 0.89
EVR 150 (124e195) 131 (105e152) 0.00
Technical success 98.4 95.2 e
LOS
TEVR 4 (3e8) 6 (3e11) 0.26
Fen 4 (3e8) 4 (2e9) 0.79
EVR 4 (2e7) 2 (2e5) 0.01
Local reintervention, % 1.4 4.8 0.05
Local complications, % 6.25 4.8 0.56
DM denotes diabetes mellitus, Cr creatinine, HD any history of ischaemic heart
disease or congestive heart failure, LOS length of stay.
a Plus-minus values are means  SD, otherwise values are median (25th to 75th
percentile).
b Chi-square tests compared categorical variables. Normally distributed contin-
uous variables were compared using Independent t tests, otherwise the Wilcoxon
rank-sum test was used.
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percutaneous access group was 73.9  9.0 years, compared with
74.3  8.0 years in the open access group. There were no statisti-
cally signiﬁcant differences between the two groups in terms of
baseline clinical characteristics.
During this 12-month observation period, percutaneous access
was technically successful in 177 CFAs (95.2%). Immediate conver-
sion to an open femoral artery cutdown following attempted
percutaneous access was required for 8 (4.3%) CFAs. Postoperative
DUS identiﬁed one femoral artery pseudoaneurysmwhich required
thrombin injection, representing the only postoperative compli-
cation in the percutaneous access group. There were no reported
cases of common femoral artery stenosis prior to discharge. In the
open access group, a local reinterventionwas required for 3 CFAs (2
evacuation of haematoma, 1 wound infection washout). Post-
operative complications in the open access group occurred in 13
patients including 4 wound infections, 4 haematomas, 3 seromas
and 2 dehisced wounds. Percutaneous access was associated with
a reduced operation length (131 min [105e152] versus 150 min
[124e195], p0.001) and length of stay (2 days [2e5] versus 4 days
[2e7], p ¼ 0.01) in patients undergoing infrarenal EVR. In patients
undergoing FEVR and TEVR, the differences observed in the length
of operation and the duration of stay between the two treatment
groups were non-signiﬁcantly different.
In the secondary analysis to determine predictors of technical
success for percutaneous access, we examined outcomes following
the insertion of 57 consecutive stent grafts using 103 femoral access
sites. The technical success rate for percutaneous accesswas 89% (81/
91). Data from8patients (12 CFAs)with relative contraindications for
percutaneous access, in whom open access was performed, were
excluded from analysis, One of these patients required bilateral CFA
endarterectomy, 3 were obese (each with a maximum CFA
depth  70 cm) and 1 had Marfans disease. Three stents were
delivered through 24 French sheaths, deemed too large for percuta-
neous closure. Amongst the cohort treated percutaneously (n ¼ 49),10 were obese (BMI  30), 5 had groin scarring and 5 CFAs had
calciﬁcation of greater than 20% of the anterior CFA wall.
Unifactorial analysis using success of percutaneous access as the
dependent variable yielded the following independent variables
(p0.10) for inclusion in our multivariate model: renal impairment,
CFA depth (MIN and MAx), CFA diameter (MIN and MAx), and operator
experience (Table 2). Of note, renal impairment demonstrated an
association with anterior CFA calciﬁcation (p ¼ 0.04). There was no
association between technical success and the sheath size
(p ¼ 0.89) (Fig. 1). In the multifactorial model, operator experience
was the only independent predictor of technical success after
adjusting for baseline variables (P ¼ 0.05).
Discussion
The goal of pEVR is to further minimise the invasiveness of
aortic surgery. Initially limited to the closure of small diameter
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to include the closure of arteriotomy sites from a range of sheath
sizes compatible with the delivery of aortic stent grafts. The present
experience using the Prostar XL device indicates that non-selective
patients undergoing EVR can be treated percutaneously with fewer
local postoperative complications, shorter operations and
a reduced length of stay.
In agreement with these observations, two recent reports of
systematically reviewed data have deﬁned several advantages of
percutaneous aortic procedures. Percutaneous EVR was associated
with decreased procedural times, reduced length of stay, earlier
ambulation and fewer access-related complications.8,9 Potential
reductions in the time to ambulation and discharge may serve to
reduce the incidence of postoperative complications associated
with immobility and improve overall cost-effectiveness of EVR. The
access-related complication rate of pEVR in the established litera-
ture is around 4.5%, which is comparable with the best open EVR
series.9 In the current series similar access-related complication
rates in percutaneous and open access groups was observed. In the
open access group the majority of complications were post-
operative whereas intraoperative open surgical dissection repre-
sented the vast majority of complications in pEVR group.
Both systematic reviews highlight the heterogeneity of patient
populations included in series evaluating the role of percutaneous
access in EVR. Key issues will be to illustrate which patients derive
most beneﬁt from a totally percutaneous approach, and to further
deﬁne those patients who have a poor chance of success. The
ﬁndings from the present study suggest that the experience of the
surgeon is a more important predictor of technical success than
obesity, groin scarring or CFA morphology. Moreover, this study
demonstrates that totally percutaneous EVR is appropriate for the
majority of patients.
Given the ﬁndings in relation to the signiﬁcance of surgeon
experience on outcome, it is important to note the learning curve
associated with use of the Prostar XL and other suture-mediated
closure devices. In the present series, operator experience was
the only independent predictor of technical success. Most series in
the literature, including the current one, report single-centre
experience that includes the learning curve. In this context there
may be a rise in the reported technical success rate of the “preclose
technique” as surgeons gain familiarity with the closure devices.
The device company recommend supervised deployment of the
Prostar XL on 10 patients prior to independent use. We extrapo-
lated this ﬁgure into the number of CFA punctures performed, using
a cut-off of 20 devices to differentiate the experienced operator
from the training operator. Following observation of approximately
5 devices, training consisted of initial device insertion with
deployment of the sutures (approximately 5 devices) followed by
both device deployment and subsequent knot tying (i.e. the entire
percutaneous procedure, with approximately 15 devices). All
training was assisted by a consultant surgeon scrubbed and
standing on the opposite side of the operating table.
We suspect that experienced operators are more likely to be
able to differentiate between a correct Prostar XL deployment and
one in which the needles are restricted due to calciﬁed plaquesduring recapture. We also speculate that an experienced operator is
alsomore likely to puncture the common femoral artery in a central
position away from calciﬁed plaques, rather than catch the lateral
or medial aspect of the vessel.
A recent meta-analysis evaluating the relationship between
technical success of pEVR and sheath size has shown favourable
outcome with the use of smaller sheath sizes (18-F).10 This
contradicts the data from the present study showing no association
between sheath size and technical success e albeit in a relatively
small sample.
Despite the potential for selection bias, the presence of obesity,
groin scarring, diabetes and CFA calciﬁcation were not signiﬁcantly
different between the two treatment groups in our secondary
analysis. The inclusion of a historical control group could poten-
tially confound our analysis of the length of stay. We recognise the
increasing use of strategies to shorten the length of hospital stay in
recent years, that are common to the vast majority of UK healthcare
institutions.
This study has demonstrated good perioperative results with
totally percutaneous EVR in a non-selective group of patients.
The study demonstrated beneﬁts in terms of reduced post-
operative complications, shorter procedures and decreased
lengths of stay.
Conﬂict of Interest/Funding
None.
References
1 Lee WA, Brown MP, Nelson PR, Huber TS, Seeger JM. Midterm outcomes of
femoral arteries after percutaneous endovascular aortic repair using the Pre-
close technique. J Vasc Surg 2008;47:919e23.
2 Eisenack M, Umsheid T, Tessarek J, Torsello GF, Torsello GB. Percutaneous
endovascular aortic aneurysm repair: a prospective evaluation of safety, efﬁ-
ciency, and risk factors. J Endovasc Ther 2009;16:708e13.
3 Jean-Baptiste E, Hassen-Khodja R, Haudebourg P, Bouillanne PJ, Declemy S,
Batt M. Percutaneous closure devices for endovascular repair of infrarenal
abdominal aortic aneurysms: a prospective, n on-randomized comparative
study. Eur J Vasc Endovasc Surg 2008;35:422e8.
4 Howell M, Villareal R, Krajcer Z. Percutaneous access and closure of femoral
artery access sites associated with endoluminal repair of abdominal aortic
aneurysms. J Endovasc Ther 2001;8(1):68e74.
5 The LG, Sieunarine K, van Schie G, Goodman MA, Lawrence-Brown M,
Prendergast FJ, et al. Use of the percutaneous vascular surgery device for closure
of femoral access sites during endovascular aneurysm repair: lessons from our
experience. Eur J Vasc Endovasc Surg 2001;2295:418e23.
6 Smith ST, Timaran CH, Valentine RJ, Rosero EB, Clagett GP, Arko FR. Percuta-
neous access for endovascular abdominal aortic aneurysm repair: can selection
criteria be expanded? Ann Vasc Surg 2009;23(5):621e6.
7 Lee AW, Brown MP, Nelson PR, Huber TS. Total percutaneous access for endo-
vascular aortic aneurysm repair (“Preclose” technique). J Vasc Surg
2007;45:1095e101.
8 Haulon S, Hassen Khodja R, Proudfoot CW, Samuels E. A systematic review of
the efﬁcacy and safety of the Prostar XL device for the closure of large femoral
arterial access sites in patients undergoing percutaneous endovascular aortic
procedures. Eur J Vasc Endovasc Surg 2011;41:201e13.
9 Malwaki AH, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM. Percutaneous
access for endovascular aneurysm repair: a systematic review. Eur J Vasc
Endovasc Surg 2010;39:676e82.
10 Georgiadis GS, Antoniou GA, Papaioakim M, Georgakarakos E, Trellopoulos G,
Papanas N, et al. A meta-analysis of outcome after percutaneous endovascular
aortic aneurysm repair using different size sheaths or endograft delivery
systems. J Endovasc Ther 2011;18:445e59.
